(a) There is an Emergency Use Auto-Injectable Epinephrine Program.
Purpose of Program
(b) The purpose of the Program is to authorize individuals employed by a participating facility to obtain and store auto-injectable epinephrine and administer auto-injectable epinephrine to individuals who are experiencing or are believed to be experiencing anaphylaxis when a physician or emergency medical services are not immediately available.
Powers and duties of participating facilities
(c)(1) Subject to paragraph (4) of this subsection, each participating facility may obtain:
(i) A prescription for a supply of auto-injectable epinephrine from a licensed physician as provided in § 13-7A-06 of this subtitle; and
(ii) A supply of auto-injectable epinephrine from a licensed pharmacist or a licensed physician as provided in § 13-7A-06 of this subtitle.
(2) Each participating facility shall store a supply of auto-injectable epinephrine obtained under paragraph (1)(ii) of this subsection:
(i) In accordance with the manufacturer's instructions; and
(ii) In a location that is readily accessible to employees or affiliated individuals in an emergency situation.
(3) Each participating facility shall designate the employees who are certificate holders or designated affiliated individuals who are certificate holders who will be responsible for the storage, maintenance, and control of the supply of auto-injectable epinephrine.
(4) A participating facility may not obtain or store auto-injectable epinephrine unless the participating facility has at least two employees or designated affiliated individuals who are certificate holders.
(5) Each participating facility shall maintain a copy of the certificate issued to an employee or a designated affiliated individual under § 13-7A-05 of this subtitle.
Added by Acts 2018, c. 527, § 1, eff. Oct. 1, 2018. Amended by Acts 2020, c. 478, § 1, eff. Oct. 1, 2020; Acts 2020, c. 479, § 1, eff. Oct. 1, 2020.
MD Code, Health - General, § 13-7A-02, MD HEALTH GEN § 13-7A-02
Current with legislation effective through July 1, 2023, from the 2023 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.